EURADOS WG13 Survey on Lu-177-PSMA Imaging & Dosimetry Methodology
The EURADOS Working Group 13, Task 5 – Dosimetry in Nuclear Medicine – has launched a survey focused on Lu-177-PSMA Imaging and Dosimetry Methodology.
This survey pursues to obtain a comprehensive overview of the current imaging and dosimetry methods used in Lu-177-PSMA therapy, as well as the status of its integration into clinical routine. The results of this survey will help identify clinical needs and address open scientific questions. In this way, the survey can subsequently guide EURADOS WG 13 in defining research priorities for future activities on determining the patient-specific pharmacokinetics and performing personalized dosimetry.
Survey link:
This survey has been designed by medical physics experts from leading European nuclear medicine clinics. It is relevant for European nuclear medicine centres that perform Lu-177-PSMA treatments. Completing the survey will take approximately 10-15 minutes. Your participation will contribute to improve healthcare—please follow the link to take part:
Important Note:
Please be aware that some hospital firewalls may block access to Google Docs. If you experience this issue, you may wish to complete the survey using a smartphone or other device.